Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies.

Yutani, Shigeru

Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies. [electronic resource] - Cancer science Sep 2017 - 1732-1738 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article

1349-7006

10.1111/cas.13301 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Agents--administration & dosage
Cancer Vaccines--administration & dosage
Carcinoma, Hepatocellular--mortality
Chemoembolization, Therapeutic
Combined Modality Therapy
Drug Resistance, Neoplasm
Feasibility Studies
Female
Humans
Kaplan-Meier Estimate
Liver Neoplasms--mortality
Male
Middle Aged
Niacinamide--administration & dosage
Phenylurea Compounds--administration & dosage
Precision Medicine
Sorafenib
T-Lymphocytes, Cytotoxic--physiology
Treatment Outcome
Vaccination
Vaccines, Subunit--administration & dosage